Nektar Therapeutics: Alopecia Update And A Look At The Road Ahead For Rezpeg (NASDAQ:NKTR)

Core Insights - Nektar Therapeutics (NKTR) is advancing the development of rezpegaldesleukin, which has shown successful results in treating atopic dermatitis and alopecia areata [1] Group 1: Company Development - The company is focusing on the continued development of rezpegaldesleukin following positive trial results [1]